Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
Aim: to evaluate prognostic and predictive value of surface-cells markers — CD44
 and CD24 in the primary tumour tissue and after neoadjuvant chemotherapy (NACT)
 in different groups of patients of breast cancer (BC). Object and methods: specimens
 ofthe primary tumour and sp...
Saved in:
| Published in: | Онкологія |
|---|---|
| Date: | 2018 |
| Main Author: | Ryspayeva, D.E. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145305 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer / D.E. Ryspayeva // Онкологія. — 2018. — Т. 20, № 1. — С. 23-27. — Бібліогр.: 32 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018)
by: D. E. Ryspayeva
Published: (2018)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)
by: S. V. Chekhun, et al.
Published: (2015)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Expression of markers of intercellular adhesion CD44 and CD24 in cells of endometrial carcinoma with high malignancy potential
by: I. P. Nesina, et al.
Published: (2019)
by: I. P. Nesina, et al.
Published: (2019)
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
by: Lyalkin, S.A., et al.
Published: (2023)
by: Lyalkin, S.A., et al.
Published: (2023)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Estimation of content of CD44+CD24– cells as additional criterion of efficiency of preventive therapy in experiment at oncopathology
by: N. A. Bondarovich, et al.
Published: (2008)
by: N. A. Bondarovich, et al.
Published: (2008)
Prognostic value of blood redox-state indicators in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2018)
by: A. P. Burlaka, et al.
Published: (2018)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)
by: D. Y. Tsyhyka, et al.
Published: (2013)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)
by: Tsyhyka, D.Y., et al.
Published: (2013)
Topoisomerase IIα determins the prognosis and response to chemotherapy in patients with operable breast cancer
by: D. E. Ryspaeva, et al.
Published: (2017)
by: D. E. Ryspaeva, et al.
Published: (2017)
Определение содержания CD44⁺CD24⁻ клеток как дополнительный критерий оценки эффективности превентивной терапии онкопатологии в эксперименте
by: Бондарович, Н.А., et al.
Published: (2008)
by: Бондарович, Н.А., et al.
Published: (2008)
Features of hepcidin expression in patients with breast cancer
by: Yu. Lukianova, et al.
Published: (2015)
by: Yu. Lukianova, et al.
Published: (2015)
The impact of locoregional treatment on survival of patients with primary metastatic breast cancer
by: Liubota, R., et al.
Published: (2017)
by: Liubota, R., et al.
Published: (2017)
Secondary edematous breast cancer: when to be operated on background of neo-adjuvant chemotherapy?
by: O. M. Bilyi, et al.
Published: (2019)
by: O. M. Bilyi, et al.
Published: (2019)
Expression of anti-apoptothic protein survivin and gene BIRC5 in primary breast carcinoma as a prognostic marker for progression of disease
by: Ya. A. Shliakhtunou
Published: (2018)
by: Ya. A. Shliakhtunou
Published: (2018)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Characterization of breast cancer DNA content profiles as a prognostic tool
by: B. I. Gerashchenko, et al.
Published: (2014)
by: B. I. Gerashchenko, et al.
Published: (2014)
Characterization of breast cancer DNA content profiles as a prognostic tool
by: Gerashchenko, B.I., et al.
Published: (2014)
by: Gerashchenko, B.I., et al.
Published: (2014)
Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: S. Akyurek, et al.
Published: (2013)
by: S. Akyurek, et al.
Published: (2013)
Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)
by: Akyurek, S., et al.
Published: (2013)
Interplay of host genome and tumour genome in bladder cancer
by: M. P. Smal, et al.
Published: (2019)
by: M. P. Smal, et al.
Published: (2019)
Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Second-line chemotherapy in patients with advanced gastric cancer
by: V. G. Bondar, et al.
Published: (2014)
by: V. G. Bondar, et al.
Published: (2014)
Combination of chemotherapy and immunotherapy in cancer patients treatment (review)
by: N. E. Prokhach, et al.
Published: (2017)
by: N. E. Prokhach, et al.
Published: (2017)
Expression of epithelial-mesenchymal transition-related genes in prostate tumours
by: Gerashchenko, G.V., et al.
Published: (2017)
by: Gerashchenko, G.V., et al.
Published: (2017)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
by: Buchynska, L.G., et al.
Published: (2009)
by: Buchynska, L.G., et al.
Published: (2009)
Human microbiota and effectiveness of cancer chemotherapy
by: Shvets, Yu.V., et al.
Published: (2023)
by: Shvets, Yu.V., et al.
Published: (2023)
Tumor infiltrating lymphocytes and their impact on the effectiveness of the preoperative chemotherapy in various molecular subtypes of locally advanced breast cancer
by: N. O. Verovkina, et al.
Published: (2017)
by: N. O. Verovkina, et al.
Published: (2017)
Quality of life of patients with ovarian cancer after cytoreductive surgery and chemotherapy
by: A. I. Rybin, et al.
Published: (2018)
by: A. I. Rybin, et al.
Published: (2018)
Analysis of the efficacy of combination treatment of ovarian cancer patients with neoadjuvant chemotherapy
by: A. A. Mikhanovskij, et al.
Published: (2014)
by: A. A. Mikhanovskij, et al.
Published: (2014)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)
by: L. A. Tashireva, et al.
Published: (2015)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: Tashireva, L.A., et al.
Published: (2015)
by: Tashireva, L.A., et al.
Published: (2015)
Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)
by: Kirkilevsky, S.I., et al.
Published: (2023)
Similar Items
-
Predictive and prognostic potential of CD44 and CD24 expression in primary tumour and after chemotherapy in patients with breast cancer
by: D. E. Ryspayeva
Published: (2018) -
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017) -
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018) -
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017) -
SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: S. V. Chekhun, et al.
Published: (2015)